NO20005547L - Myelin base protein peptides and uses thereof - Google Patents
Myelin base protein peptides and uses thereofInfo
- Publication number
- NO20005547L NO20005547L NO20005547A NO20005547A NO20005547L NO 20005547 L NO20005547 L NO 20005547L NO 20005547 A NO20005547 A NO 20005547A NO 20005547 A NO20005547 A NO 20005547A NO 20005547 L NO20005547 L NO 20005547L
- Authority
- NO
- Norway
- Prior art keywords
- protein peptides
- base protein
- myelin base
- myelin
- peptides
- Prior art date
Links
- 102000006386 Myelin Proteins Human genes 0.000 title 1
- 108010083674 Myelin Proteins Proteins 0.000 title 1
- 210000005012 myelin Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Rehabilitation Therapy (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7310998A | 1998-05-05 | 1998-05-05 | |
| PCT/US1999/009930 WO1999057241A2 (en) | 1998-05-05 | 1999-05-05 | Myelin basic protein peptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005547D0 NO20005547D0 (en) | 2000-11-03 |
| NO20005547L true NO20005547L (en) | 2001-01-02 |
Family
ID=22111789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005547A NO20005547L (en) | 1998-05-05 | 2000-11-03 | Myelin base protein peptides and uses thereof |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1080185A4 (en) |
| JP (1) | JP2002513558A (en) |
| CN (1) | CN1308671A (en) |
| AU (1) | AU3789099A (en) |
| CA (1) | CA2330826A1 (en) |
| HK (1) | HK1039636A1 (en) |
| NO (1) | NO20005547L (en) |
| NZ (1) | NZ507901A (en) |
| WO (1) | WO1999057241A2 (en) |
| ZA (1) | ZA200006268B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7265208B2 (en) | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
| JP4538192B2 (en) * | 2001-05-01 | 2010-09-08 | ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | Fusion molecules and methods for treating immune disorders |
| ITFI20010114A1 (en) | 2001-06-22 | 2002-12-22 | Univ Firenze | GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE IN THE DIAGNOSIS OR THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS |
| ES2627306T3 (en) * | 2007-11-20 | 2017-07-27 | Vianex S.A. | Peptide analogs and conjugates thereof |
| KR20200020966A (en) * | 2015-03-30 | 2020-02-26 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | Immunizing peptide, method for producing immunizing peptide, pharmaceutical composition for immune disorders containing same, and method for treating immune disorders |
| JP7818405B2 (en) * | 2019-06-18 | 2026-02-20 | ザ スクリプス リサーチ インスティテュート | Methods and compositions for treating inflammatory conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5734023A (en) * | 1991-11-19 | 1998-03-31 | Anergen Inc. | MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses |
| CZ122697A3 (en) * | 1994-10-25 | 1997-09-17 | Immulogic Pharma Corp | Preparations and methods of treating disseminated sclerosis |
| WO1996040944A2 (en) * | 1995-06-07 | 1996-12-19 | Zymogenetics, Inc. | Fused soluble mhc heterodimer:peptide complexes and their uses |
-
1999
- 1999-05-05 AU AU37890/99A patent/AU3789099A/en not_active Abandoned
- 1999-05-05 CA CA002330826A patent/CA2330826A1/en not_active Abandoned
- 1999-05-05 WO PCT/US1999/009930 patent/WO1999057241A2/en not_active Ceased
- 1999-05-05 NZ NZ507901A patent/NZ507901A/en unknown
- 1999-05-05 CN CN99808248A patent/CN1308671A/en active Pending
- 1999-05-05 HK HK02101092.3A patent/HK1039636A1/en unknown
- 1999-05-05 JP JP2000547197A patent/JP2002513558A/en active Pending
- 1999-05-05 EP EP99920379A patent/EP1080185A4/en not_active Withdrawn
-
2000
- 2000-11-02 ZA ZA200006268A patent/ZA200006268B/en unknown
- 2000-11-03 NO NO20005547A patent/NO20005547L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999057241A2 (en) | 1999-11-11 |
| HK1039636A1 (en) | 2002-05-03 |
| EP1080185A4 (en) | 2005-01-26 |
| NZ507901A (en) | 2003-06-30 |
| WO1999057241A9 (en) | 2000-02-17 |
| NO20005547D0 (en) | 2000-11-03 |
| WO1999057241A3 (en) | 2000-01-13 |
| CA2330826A1 (en) | 1999-11-11 |
| ZA200006268B (en) | 2001-08-22 |
| EP1080185A2 (en) | 2001-03-07 |
| JP2002513558A (en) | 2002-05-14 |
| CN1308671A (en) | 2001-08-15 |
| AU3789099A (en) | 1999-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITMI982280A0 (en) | SOME N-(2-APRIL-PROPIONIL)-SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THEM | |
| NO20000700D0 (en) | Interleukin-18 proteins and their preparation and use | |
| NO20040246L (en) | TACIs and BR3 polypeptides and uses thereof | |
| EP1461605A4 (en) | Protein and peptide nanoarrays | |
| NO982097L (en) | peptides | |
| NO982098D0 (en) | peptides | |
| NO991150D0 (en) | Pyrazolopyrimidines and pyrazolotriazines | |
| IS4496A (en) | Peptide and protein aerosols | |
| NO20034962D0 (en) | Beta-amyloid peptide-binding proteins and polynucleotides encoding the same | |
| DE69822917D1 (en) | Sample and hold circuit | |
| IS6181A (en) | Single and double accessible 3-propyl-gamma amino butyric acids | |
| EP1056465A4 (en) | ANTIMICROBIAL PEPTIDES AND DERIVED METAPEPTIDES | |
| NO20040880L (en) | Casein-derived peptides and applications thereof in therapy. | |
| DE69705017D1 (en) | Drug binding protein | |
| NO995062D0 (en) | <Beta> -anyloid peptide binding proteins and polynuldeotides encoded for the same | |
| GB9918155D0 (en) | Proteins and peptides | |
| NO20005547D0 (en) | Myelin-based protein peptides and uses thereof | |
| DE69816241D1 (en) | ACTIVATED PEPTIDES AND CONJUGATES | |
| ATA1972000A (en) | RECOMBINANTLY MADE INTESTINAL NPT2B POLYPEPTIDE | |
| TR199701666A3 (en) | Proteins | |
| DK1042286T3 (en) | Gamma-glutamyl- and beta-aspartyl-containing immunomodulatory compounds and associated methods | |
| IL153740A0 (en) | Grf2-binding proteins and applications thereof | |
| NO20020794D0 (en) | Me-1 protein | |
| GB0102447D0 (en) | Protein variants and uses thereof | |
| NO20002832D0 (en) | Human thyroid protein ZSig45 and DNA encoding this |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |